(13-244) Incidence of T-cell mediated rejection in obese vs non-obese kidney transplant recipients receiving belatacept maintenance therapy.

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: Inova Fairfax Medical Campus
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Virginia

Co-Author(s): Joshua Hildebrand

Primary Author(s)